Five-year net survival for the rare disease has doubled in recent years but more research is needed to better understand the condition, writes Michael McHale While relatively uncommon, myelofibrosis patients thankfully face significantly better outcomes now than in years gone by. A type of cancer that disrupts the body’s normal production of blood cells, myelofibrosis … Read more
A machine learning model generated by a team from the European Society for Blood and Marrow Transplantation (EBMT) outperformed standard statistical models in identifying and stratifying transplant risk for patients with myelofibrosis, according to new research published today in Blood, the American Society of Hematology’s flagship journal. “Although there are many models available to identify … Read more
A machine learning model generated by a team from the European Society for Blood and Marrow Transplantation (EBMT) outperformed standard statistical models in identifying and stratifying transplant risk for patients with myelofibrosis, according to new research published today in Blood, the American Society of Hematology’s flagship journal. “Although there are many models available to identify … Read more
Results of a nationwide Swedish population-based study indicate that patients with myelofibrosis (MF) have increased rates of thromboembolic events and major bleeding compared with presentations in other myeloproliferative neoplasms (MPN), with thromboembolic complications and major bleeding events diverging based on varying treatment groups. These results, published by study authors in Blood Advances, can help health … Read more